EUVIMEDEUVIMED entdecken
Open Access

A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY

Zhidan Zhang, Meijie Chen, Yitong Xu, Zhihua Wang, Zhenghong Liu, Chenyang He, Fanshun Zhang, Xiaojun Feng, Xiayun Ni, Yuanli Chen, Jixia Wang, Xinmiao Liang und 15 weitere

Theranostics · 2025

DOI: 10.7150/thno.105782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Zhidan Zhang und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sc…. Hauptthemen laut MEDLINE: Atherosclerosis, Hypercholesterolemia, ATP Citrate (pro-S)-Lyase. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisHypercholesterolemiaATP Citrate (pro-S)-LyaseAnimalsMiceDisease Models, AnimalHumansCricetinaeMice, Inbred C57BLMaleMice, Knockout

Stichwörter der Autor:innen

ATP-Citrate lyase (ACLY)AtherosclerosisHyperlipidemiaIsoginkgetinlipid metabolism

Substanzen

ATP Citrate (pro-S)-Lyase

Autor:innen und Institutionen

  • Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, He…
  • Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, Beijing, China.
  • Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, College of Food and Biological Engineering, Hefei University of Technology, Hefei, China.
  • Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
  • State Key Laboratory of Drug Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Shanghai, 201203, China.
  • Department of Preventive Cardiology and Lipidology, Medical University of Lodz 23 (MUL), Rzgowska 281/289, 93-338, Lodz, Poland.

Zitieren

APA

Zhang, Z., Chen, M., Xu, Y., Wang, Z., Liu, Z., He, C., Zhang, F., Feng, X., Ni, X., Chen, Y., Wang, J., Liang, X., Xie, Z., Li, J., Banach, M., Pelisek, J., Huo, Y., Hu, Y., Evans, P. C., …, & Xu, S. (2025). A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY. Theranostics. https://doi.org/10.7150/thno.105782

Vancouver

Zhang Z, Chen M, Xu Y, Wang Z, Liu Z, He C, et al. A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY. Theranostics. 2025. doi:10.7150/thno.105782

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhidan and Chen, Meijie and Xu, Yitong and Wang, Zhihua and Liu, Zhenghong and He, Chenyang and Zhang, Fanshun and Feng, Xiaojun and Ni, Xiayun and Chen, Yuanli and Wang, Jixia and Liang, Xinmiao and Xie, Zhifu and Li, Jingya and Banach, Maciej and Pelisek, Jaroslav and Huo, Yuqing and Hu, Yunhui and Evans, Paul C and Wang, Li and Tian, Xiao-Yu and Xiao, Jianbo and Shang, Yuhua and Zheng, Yijun and Xian, Xunde and Weng, Jianping and Xu, Suowen},
  title = {A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.105782}
}
Kostenlos starten →